Pharmacokinetics and Bioequivalence study of ranitidine film tablets in healthy male subjects

Gschwend M. H., Guserle R., Erenmemisoglu A., Martin W., Tamur U., Kanzik I., ...Daha Fazla

ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, cilt.57, sa.6, ss.315-319, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 6
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1055/s-0031-1296625
  • Dergi Adı: ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.315-319
  • Anahtar Kelimeler: CAS 66357-35-5, CAS 66357-59-3, histamine H-2-receptor antagonists, Ranitab (R), ranitidine hydrochloride, bioequivalence, pharmacokinetics, BIOAVAILABILITY, KINETICS
  • Gazi Üniversitesi Adresli: Hayır

Özet

The aim of the present study was to compare the bioavailability of ranitidine (CAS 66357-35-5) from two different ranitidine hydrochloride (CAS 66357-59-3) film tablets (Ranitab((R)) 150 mg film tablets as test preparation and 150 mg film tablets of the originator product as reference preparation). The study was conducted according to an open-label, randomised two-period cross-over design with a wash-out phase of 9 days.